Production (Stage)
Devonian Health Group Inc.
DVHGF
$0.18
$0.036225.17%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 198.18% | 453.72% | 589.63% | 667.18% | 432.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 198.18% | 453.72% | 589.63% | 667.18% | 432.66% |
| Cost of Revenue | 198.52% | 522.67% | 673.34% | 700.83% | 454.54% |
| Gross Profit | 197.51% | 350.28% | 469.79% | 612.36% | 395.03% |
| SG&A Expenses | 47.73% | 51.85% | 88.45% | 56.01% | 50.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.45% | 1.47% | 2.86% | 3.70% | 3.48% |
| Total Operating Expenses | 126.42% | 206.39% | 229.07% | 183.19% | 113.29% |
| Operating Income | 129.00% | 114.37% | 79.42% | 79.98% | 31.94% |
| Income Before Tax | -22.84% | 106.84% | 72.96% | 73.32% | 30.57% |
| Income Tax Expenses | 53.75% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.27% | 90.84% | 66.42% | 67.48% | 24.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.27% | 90.84% | 66.42% | 67.48% | 24.66% |
| EBIT | 129.00% | 114.37% | 79.42% | 79.98% | 31.94% |
| EBITDA | 156.81% | 132.30% | 94.75% | 93.95% | 35.18% |
| EPS Basic | -24.86% | 91.07% | 68.47% | 70.20% | 32.68% |
| Normalized Basic EPS | 121.00% | 105.71% | 74.10% | 74.84% | 37.89% |
| EPS Diluted | -15.51% | 91.60% | 65.13% | 66.67% | 36.39% |
| Normalized Diluted EPS | 121.21% | 106.43% | 74.82% | 75.47% | 38.51% |
| Average Basic Shares Outstanding | 0.96% | 3.66% | 5.93% | 8.40% | 11.56% |
| Average Diluted Shares Outstanding | 0.63% | 6.06% | 8.40% | 10.94% | 14.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |